KR101116180B1 - The microbial fermented products of androgen from natural products containing sterol and its production method - Google Patents

The microbial fermented products of androgen from natural products containing sterol and its production method Download PDF

Info

Publication number
KR101116180B1
KR101116180B1 KR1020090027297A KR20090027297A KR101116180B1 KR 101116180 B1 KR101116180 B1 KR 101116180B1 KR 1020090027297 A KR1020090027297 A KR 1020090027297A KR 20090027297 A KR20090027297 A KR 20090027297A KR 101116180 B1 KR101116180 B1 KR 101116180B1
Authority
KR
South Korea
Prior art keywords
androgen
fermentation
sterol
sterols
androgens
Prior art date
Application number
KR1020090027297A
Other languages
Korean (ko)
Other versions
KR20100108958A (en
Inventor
이강만
Original Assignee
이화여자대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이화여자대학교 산학협력단 filed Critical 이화여자대학교 산학협력단
Priority to KR1020090027297A priority Critical patent/KR101116180B1/en
Priority to PCT/KR2010/001858 priority patent/WO2010114255A2/en
Publication of KR20100108958A publication Critical patent/KR20100108958A/en
Application granted granted Critical
Publication of KR101116180B1 publication Critical patent/KR101116180B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 미생물을 이용하여 스테롤포함 천연물을 발효하여 얻어진 안드로겐 함유 발효생성물 및 이의 제조방법에 관한 것으로서, 구체적으로는 스테롤을 포함하는 동물성 또는 식물성 천연물에 스테롤의 측쇄를 분해하는 능력을 가지는 미생물을 접종하여 발효시켜 안드로겐을 포함하는 발효생성물을 제조함으로써 남성의 갱년기 장해 또는 안드로겐 결핍에 의하여 발생하는 건강의 이상 현상을 억제하거나 치료할 수 있는 안드로겐을 포함하는 발효생성물을 제공한다.The present invention relates to an androgen-containing fermentation product obtained by fermenting a sterol-containing natural product using a microorganism and a method for preparing the same, and specifically, inoculating a microorganism having an ability to decompose a side chain of sterol to an animal or vegetable natural product including a sterol By fermentation to produce a fermentation product containing androgen to provide a fermentation product containing androgens capable of inhibiting or treating abnormalities in health caused by menopausal disorders and androgen deficiency in men.

본 발명의 안드로겐을 포함하는 발효생성물은 안드로겐 결핍에 따른 현상에 건강보조제 또는 치료제로 유용하게 사용될 수 있다.Fermentation products containing androgen of the present invention can be usefully used as a health supplement or therapeutic agent in the phenomenon caused by androgen deficiency.

안드로겐, 동물성 스테롤, 식물성 스테롤, 스테롤 분해 미생물, 발효 Androgens, animal sterols, vegetable sterols, sterol degrading microorganisms, fermentation

Description

미생물을 이용하여 스테롤포함 천연물을 발효하여 얻어진 안드로겐 함유 발효생성물 및 이의 제조방법 {The microbial fermented products of androgen from natural products containing sterol and its production method}Androgen-containing fermentation products obtained by fermenting a natural product containing sterols using microorganisms and a method for preparing the same {The microbial fermented products of androgen from natural products containing sterol and its production method}

본 발명은 미생물을 이용하여 스테롤포함 천연물을 발효하여 얻어진 안드로겐 함유 발효생성물 및 이의 제조방법에 관한 것으로서, 구체적으로는 스테롤을 포함하는 동물성 또는 식물성 천연물에 스테롤의 측쇄를 분해하는 능력을 가지는 미생물을 접종하여 발효시켜 안드로겐을 포함하는 발효생성물을 제조함으로써 남성의 갱년기 장해 또는 안드로겐 결핍에 의하여 발생하는 건강의 이상 현상을 억제하거나 치료할 수 있는 안드로겐을 포함하는 발효생성물에 관한 것이다.The present invention relates to an androgen-containing fermentation product obtained by fermenting a sterol-containing natural product using a microorganism and a method for preparing the same, and specifically, inoculating a microorganism having an ability to decompose a side chain of sterol to an animal or vegetable natural product including a sterol By fermentation to produce a fermentation product containing androgen, and relates to a fermentation product containing androgens capable of inhibiting or treating abnormal health symptoms caused by menopausal disorders and androgen deficiency in men.

사람의 수명연장에 따른 노령인구의 증가와 비례하여 갱년기 장애를 호소하는 사람들이 증가하는 추세이다. 이러한 갱년기 장애의 주요한 원인으로 성호르몬의 결핍 또는 생성저하를 생각할 수 있다. 갱년기 장애를 극복하는 방법으로 여성의 경우는 여성 성호르몬인 에스트로겐을 주기적으로 투여하는 호르몬요법이 시행되고 있으며, 남성의 경우는 남성 성호르몬인 테스토스테론 등의 안드로겐을 적용하는 호르몬요법이 시행되고 있다. 그러나 이러한 성 호르몬 대체요법은 합성 정제된 여성 또는 남성 성 호르몬을 의료기관에서 시행하는 방법이며 일반인이 손쉽게 이용할 수 없는 문제점이 있다. 따라서 동물성 또는 식물성 천연물을 발효시켜 얻어지는 발효산물에 성 호르몬 또는 성 호르몬 유사물질을 생성물에 포함시킬 수 있다면 성호르몬 결핍 또는 불균형에서 오는 건강상의 이상증상을 억제 또는 치유할 수 있을 것이다.The number of people who complain of menopausal disorders is increasing in proportion to the increase in the elderly population as the life span of people increases. The main cause of these menopausal disorders is the lack of sex hormones or reduced production. As a method of overcoming menopausal disorders, women are receiving hormonal therapy to periodically administer estrogen, a female sex hormone, and men, and hormone therapy to apply androgens, such as testosterone, a male sex hormone. However, such sex hormone replacement therapy is a method of administering synthetic purified female or male sex hormone in a medical institution, and there is a problem that is not readily available to the general public. Therefore, if the fermentation product obtained by fermenting animal or plant natural products can include sex hormones or sex hormone-like substances in the product, it would be possible to suppress or heal the health abnormalities resulting from sex hormone deficiency or imbalance.

또한 계란의 경우 다량으로 함유되어 있는 콜레스테롤을 발효과정을 통하여 감소시키거나 제거함으로써 성인의 콜레스테롤 과다섭취를 염려하는 경우에 저스테롤 또는 무스테롤 계란발효산물을 제공할 수 있다. In addition, in the case of eggs by reducing or eliminating the cholesterol contained in a large amount through the fermentation process can provide a low-sterol or nosterol egg fermentation products in case of concern about excessive intake of cholesterol in adults.

본 발명은 스테롤의 측쇄를 분해할 수 있는 미생물을 계란 등 스테롤을 포함하고 있는 천연물에 접종하여 발효시켜 안드로겐을 포함하는 발효조성물을 생산함으로써 남성의 갱년기 장해 또는 안드로겐 결핍에 의하여 발생하는 건강의 이상 현상을 억제하거나 치료할 수 있는 안드로겐을 포함하는 발효생성물 및 이의 제조방법에 관한 것이다.The present invention inoculates and ferments microorganisms capable of degrading the side chains of sterols into natural products containing sterols such as eggs to produce fermentation compositions containing androgens, thereby causing abnormal health effects caused by menopausal disorders and androgen deficiency in men. It relates to a fermentation product containing androgen that can inhibit or treat and a method for producing the same.

본 발명의 목적은 스테롤의 측쇄를 분해할 수 있는 미생물을 계란 등 스테롤을 다량 포함하고 있는 천연물에 접종하여 발효시켜 저스테롤 또는 무스테롤이며, 안드로겐을 포함하는 발효조성물을 생산함으로써 남성의 갱년기 장해 또는 안드로겐 결핍에 의하여 발생하는 건강의 이상 현상을 억제하거나 치료할 수 있는 안드로겐을 포함하는 조성물을 제공한다.An object of the present invention is to inoculate microorganisms capable of degrading the side chains of sterols into natural products containing a large amount of sterols such as eggs and fermented to produce fermentation compositions containing low and no sterols, and androgen. Provided are compositions comprising androgens capable of inhibiting or treating abnormalities in health caused by androgen deficiency.

상기 목적을 달성하기 위하여, 본 발명은 스테롤의 측쇄를 분해할 수 있는 Mycobacterium 속, Arthrobacter 속, Norcadia 속, Brevibacterium 속 등 미생물, 바람직하게는 Mycobacterium 속 미생물을 계란 등 스테롤을 다량 포함하고 있는 천연물에 접종하여 발효시켜 최종 스테롤 함량이 초기 스테롤 함량의 50 중량% 이하의 저스테롤 또는 무스테롤이며, 안드로겐을 포함하는 발효조성물을 제공한다.In order to achieve the above object, the present invention is inoculated microorganisms, such as Mycobacterium genus, Arthrobacter genus, Norcadia genus, Brevibacterium genus which can decompose the side chains of sterols, preferably Mycobacterium genus microorganisms in natural products containing a large amount of sterols such as eggs To fermentation composition having a final sterol content of 50% by weight or less of the initial sterol content or low sterol or musterol, and androgen.

본 발명에서는 미생물을 포도당이 포함된 배양배지에서 섭씨 30도에서 5일간 진탕배양하여 배양액을 종배양액으로 이용한다.In the present invention, the culture medium is shaken for 5 days at 30 degrees Celsius in a culture medium containing glucose to use the culture medium as a seed culture.

본 발명에서 발효 시 미생물의 종배양액은 스테롤을 포함하는 천연물 중량에 대해 5~1000중량% 양으로 사용하며, 바람직하게는 10~500 중량% 사용한다.In the present invention, the seed culture medium of the microorganism during fermentation is used in an amount of 5 to 1000% by weight based on the weight of the natural product including sterol, preferably 10 to 500% by weight.

본 발명에서 이용 가능한 스테롤 함유 천연물에는 계란, 오리알, 메추리알 등의 동물성 천연물과 카카오, 콩, 마(산약, 천마), 저령, 인삼 등의 식물성 천연물이 있다.The sterol-containing natural products usable in the present invention include animal natural products such as eggs, duck eggs, quail eggs, and vegetable natural products such as cacao, soybeans, hemp (fermented herbs, cheonma), nymph, ginseng.

배양배지는 nutrient broth(beef extract 3g, peptone 8g, 물 1000ml), yeast extract-malt extract broth(yeast extract 4g, malt extract 10g, glucose 4g, 물 1000ml), tryptone glucose broth(glucose 10g, sodium nitrate 1g, K2HPO4 0.5g, MgSO4 0.5g, urea 0.5g, FeCl3 50mg, tryptic soy broth 1g, 물 1000ml) 등이 사용될 수 있으며, 발효에 사용하는 미생물에 따라 배양배지는 달라질 수 있다.The culture medium was nutrient broth (3g bee extract, 8g peptone, 1000ml water), yeast extract-malt extract broth (yeast extract 4g, malt extract 10g, glucose 4g, water 1000ml), tryptone glucose broth (10g glucose, 1g sodium nitrate, 0.5 g of K 2 HPO 4, 0.5 g of MgSO 4, 0.5 g of urea, 50 mg of FeCl 3 , 1 g of tryptic soy broth, and 1000 ml of water) may be used, and the culture medium may vary depending on the microorganism used for fermentation.

포도당의 농도는 배양배지 중량의 0.1~5중량 %가 바람직하며, 보다 바람직하게는 1.5~3.0 중량% 농도로 첨가하여 사용한다.The concentration of glucose is preferably 0.1 to 5% by weight of the culture medium weight, more preferably 1.5 to 3.0% by weight is used to add.

본 발명에서 발효기간은 5일 내지 100 일이고, 발효시 온도는 섭씨 20~40도로 유지하는 것이 바람직하며, 보다 바람직하게는 10~40일간, 섭씨 25~35도로 유지하는 것이 좋다.In the present invention, the fermentation period is 5 days to 100 days, the fermentation temperature is preferably maintained at 20 to 40 degrees Celsius, more preferably 10 to 40 days, 25 to 35 degrees Celsius.

본 발명은 스테롤의 측쇄를 분해할 수 있는 미생물을 계란 등 스테롤을 포함하고 있는 천연물에 접종하여 발효시켜 저스테롤 또는 무스테롤이며, 안드로겐을 포함하는 발효조성물을 생산함으로써 남성의 갱년기 장해 또는 안드로겐 결핍에 의하여 발생하는 건강의 이상 현상을 억제하거나 치료할 수 있는 안드로겐을 포함하는 발효산물을 생산함으로써 이를 이용하여 손쉽게 안드로겐 결핍에서 오는 갱년기 장애를 예방하거나 치료할 수 있어 고령화 사회에서 노인건강유지를 위하여 유용하게 사용될 수 있다.The present invention is inoculated by fermentation of a microorganism capable of decomposing the side chains of sterols into natural products containing sterols such as eggs and fermented low-sterol or musterol, and by producing a fermentation composition containing androgen to prevent menopausal disorders and androgen deficiency in men By producing a fermentation product containing androgens that can suppress or treat the health problems caused by the health, by using it can easily prevent or treat menopausal disorders resulting from androgen deficiency can be useful for maintaining elderly health in an aging society have.

이하, 본 발명을 하기 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by the following examples.

제조예: 미생물 종배양액의 제조Preparation Example: Preparation of Microbial Species Culture Solution

Mycobacterium 속 M3805 균주(KCTC 1829)를 포도당이 1중량% 포함된 nutrient broth 배지에 접종하여 섭씨 30도에서 5일간 진탕배양하고, 배양액을 종배양액으로 이용한다. Mycobacterium spp. M3805 strain (KCTC 1829) was inoculated in a nutrient broth medium containing 1% by weight of glucose and shaken at 30 ° C for 5 days, and the culture medium was used as the seed culture solution.

박층크로마토그래피법에 의한 정성분석Qualitative analysis by thin layer chromatography

실리카겔 박층판에 시료를 점적하고 클로로포름 : 에틸에테르 혼합액(10:2.5)에서 전개하여 용매를 말린 다음 자외선 하에서 자외선 흡수를 보이는 안드로겐 등의 물질의 존재를 확인하고, 10% 황산용액을 분무하고 섭씨 80 - 90 도 오븐에서 1시간 가열하여 발색시킨 후 스테롤 및 안드로겐 등의 물질을 확인한다.Samples were deposited on a thin layer of silica gel and developed in a mixture of chloroform: ethyl ether (10: 2.5) to dry the solvent, and then checked for the presence of substances such as androgens, which showed ultraviolet absorption under ultraviolet light, and sprayed with 10% sulfuric acid solution at 80 degrees Celsius. -Heat for 1 hour in a 90-degree oven to develop colors and check for materials such as sterols and androgens.

가스크로마토그래피법에 의한 정량분석Quantitative Analysis by Gas Chromatography

스테로이드 분석용 칼럼이 부착된 가스크로마토그래피 기기를 이용하여 시료 중에 포함되어 있는 물질들을 분리하고 불꽃검출기로 검출하여 각각의 유지시간을 확인하고 피크면적으로부터 물질의 양을 정량한다.Using a gas chromatography device with a column for steroid analysis, the substances contained in the sample are separated and detected by a flame detector to check the respective retention time and quantify the amount of the substance from the peak area.

실시예 1. Example 1. MycobacteriumMycobacterium 속 세균을 이용한 Bacteria 발효에서 안드로겐의 생성에 적합한 포도당 첨가농도 결정Determination of Glucose Concentrations Suitable for Androgen Production in Fermentation

스테롤로부터 테스토스테론을 포함한 안드로겐의 발효에 적합한 포도당농도를 결정하기위하여 영양배지(nutrient broth; beef extract 3g, peptone 8g, 물 1000ml)에 포도당을 0.75%, 1.5%, 2%, 3% 농도로 첨가하고 콜레스테롤을 0.1% 농도로 포함한 배양배지에서 Mycobacterium 속 M3805 균주(KCTC 1829)를 접종하여 20일 동안 섭씨 30도에서 진탕배양하여 발효액을 에틸아세테이트로 추출하여 실리카겔 박층크로마토그래피법으로 분석하였다.To determine the glucose concentration suitable for the fermentation of androgens including testosterone from sterols, glucose was added to the broth (nutrient broth; beef extract 3g, peptone 8g, water 1000ml) at 0.75%, 1.5%, 2% and 3% concentrations. Mycobacterium sp. M3805 strain (KCTC 1829) was inoculated in a culture medium containing cholesterol at 0.1% concentration and shaken at 30 ° C. for 20 days. The fermentation broth was extracted with ethyl acetate and analyzed by silica gel thin layer chromatography.

도 1에서 보는 바와 같이 포도당을 3% 첨가농도에서 4-안드로스텐디온 이외에도 테스토스테론의 생성이 현저하였다. 따라서 발효배지에서 포도당의 농도를 3%로 조정함으로써 테스토스테론의 생성을 향상시킬 수 있다.As shown in FIG. 1, the production of testosterone was remarkable in addition to 4-androstenedione at the concentration of 3% glucose. Therefore, it is possible to improve the production of testosterone by adjusting the concentration of glucose to 3% in fermentation broth.

실시예 2. 계란의 Example 2. Eggs MycobacteriumMycobacterium 속 세균을 이용한 Bacteria 발효에서 안드로겐의 생성확인과 경시적 변화Confirmation and Changes of Androgen Production in Fermentation

종배양액 100 mL에 계란 1개의 내용물을 무균적으로 주가하고, 섭씨 30도에 서 진탕배양하면서 10일 간격으로 배양액을 채취하여 에틸아세테이드 용매를 사용하여 추출하고, 추출액을 박층크로마토그래피 또는 가스크로마토그래피 분석을 시행하여 발효액에 포함되어 있는 콜레스테롤과 그의 분해산물인 안드로겐의 존재를 확인하였다.Aseptically add the contents of one egg to 100 mL of the cultivation solution, extract the culture solution every 10 days with shaking culture at 30 degrees Celsius, extract with ethyl acetate solvent, and extract the thin layer chromatography or gas. Chromatographic analysis was performed to confirm the presence of cholesterol and androgen, a degradation product thereof, contained in the fermentation broth.

도 2에서 보는 바와 같이 발효일수가 증가함에 따라 스테롤의 양은 감소하고 안드로겐 물질은 증가하여 40일 배양에서는 스테롤의 반점은 거의 관찰되지 않았고 안드로겐 물질들의 반점들을 현저하게 확인할 수 있었다.As shown in FIG. 2, as the fermentation days increase, the amount of sterol decreases and the androgen substance increases, and almost no spot of sterol was observed in the 40-day culture, and the spots of the androgen substances were remarkably confirmed.

또한, 물질의 경시적 변화를 정량하기위하여 가스크로마토그래피를 이용한 분석을 시행한 결과는 표 1에서와 보는 바와 같았다. 시간 경과에 따라서 콜레스테롤은 감소하고 안드로겐 물질은 축적됨을 확인할 수 있었다.In addition, the results of the analysis using gas chromatography to quantify the change over time was as shown in Table 1. Over time, cholesterol was decreased and androgen was accumulated.

발효시간에 따른 발효액(ml 당) 중 스테롤과 안드로겐의 변화 Changes in Sterols and Androgens in Fermentation Broth (per ml) with Fermentation Time 발효일수(일)Effective date (days) 스테롤의 양(㎍)Amount of sterol (μg) 4-안트로스텐디온의 양(㎍)Amount of 4-anthrostenedione (μg) 테스토스테론(㎍)Testosterone (μg) 00 10521052 -- -- 1010 722722 -- -- 2020 526526 5656 -- 3030 176176 226226 -- 4040 1818 354354 2424

실시예 3. 첨가된 계란 양에 따른 콜레스테롤과 안드로겐의 변화Example 3 Changes in Cholesterol and Androgen According to the Added Egg Volume

계란 내용물을 혼화하고 그의 혼화물을 25 ml, 38 ml, 50 ml, 75 ml 씩을 미생물종배양 100 ml 에 각각 주가하고 배양하여 스테롤의 소진과 안드로겐의 생성에 소요되는 시간과 안드로겐의 양을 실험하였다.The contents of the eggs were mixed, and the mixtures were mixed with 100 ml of microbial culture and 25 ml, 38 ml, 50 ml, and 75 ml of each were mixed and cultured, and the time and amount of androgen for sterol exhaustion and androgen production were examined. .

도 3에서 보는 바와 같이 같은 양의 종배양액에 계란 내용물의 첨가량을 변화시켰을 때 첨가량이 많을수록 스테롤이 소실되는데 걸리는 발효시간이 길어짐을 알 수 있었다. 75 ml를 첨가한 경우는 50일 발효에서도 스테롤이 잔존하고 있음을 확인할 수 있었다. 표 2는 가스크로마토그래피를 이용한 안드로겐의 정량 결과이다.As shown in FIG. 3, when the amount of the egg contents was changed in the same amount of the seed culture solution, the more the amount added, the longer the fermentation time required to lose the sterol. When 75 ml was added, it could be confirmed that sterol remained in the 50-day fermentation. Table 2 shows the quantitative results of androgens using gas chromatography.

첨가된 달걀 양에 따른 스테롤과 안드로겐의 변화 Changes in Sterols and Androgens According to the Added Egg Volume 달걀 내용물 주가량Egg Content Stock Price 25 ml25 ml 38 ml38 ml 50 ml50 ml 75 ml75 ml 콜레스테롤이 소진되는데 걸리는 배양일수Number of days spent cultivating cholesterol 25일25 days 35일35 days 40일40 days 60일 이상60 days or more 발효액 ml 당 4-androstendione의 생성량(㎍)Production amount of 4-androstendione per ml of fermentation broth (μg) 250250 328328 366366 184184 발효액 ml 당 잔존 콜레스테롤의 양(㎍)Amount of residual cholesterol per ml of fermentation broth (μg) -- -- -- 194194

실험예 4.Experimental Example 4. 발효생성물의 안드로겐의 효과Effect of Androgen in Fermentation Products

안드로겐을 함유하는 발효생성물 건조물 2g(1440㎍ 안드로겐 함유)을 로션 베이스 45ml에 혼화하여 저녁에 눈썹에 적용함을 3개월 시행한 결과 도 4에서 보는 바와 같이 눈썹의 색깔과 수의 증가를 확인할 수 있었다. 이러한 결과는 발효산물 중에 있는 안드로겐이 인체에 작용하여 효과를 나타냄을 생리학적으로 보여주는 결과이다. 따라서 발효생성물을 인체에 적용할 수 있는 적절한 제형(로션, 패취, 캡슐 등)으로 만들어 안드로겐의 결핍 또는 생성저하에서 나타나는 생리적 현상을 완화 또는 방지하는데 유용하게 이용할 수 있을 것이다.As a result of 3 months of application to the eyebrows in the evening, mixed with 2 g of a fermentation product containing androgen (containing 1440 ㎍ androgen) in a lotion base 45 ml, the color and number of eyebrows were increased as shown in FIG. . These results are physiologically showing that androgens in fermentation products act on the human body and show effects. Therefore, the fermentation product may be usefully applied to alleviate or prevent physiological phenomena occurring in androgen deficiency or degradation by making an appropriate formulation (lotion, patch, capsule, etc.) applicable to the human body.

도 1은 Mycobacterium 속 세균을 이용한 발효에서 포도당 첨가농도 변화에 따른 결과를 보여준다.Figure 1 shows the result of the glucose concentration changes in the fermentation using the bacteria Mycobacterium genus.

도 2는 TLC에 의한 계란의 Mycobacterium 속 세균을 이용한 발효에서 안드로겐의 생성과 경시적 변화를 보여준다.Figure 2 shows the androgen production and changes over time in the fermentation of Mycobacterium sp. Bacteria of eggs by TLC.

도 3은 TLC에 의한 계란내용물 첨가량의 변화와 발효액 중 잔존 콜레스테롤의 확인과 안드로겐의 생성의 확인을 보여준다.Figure 3 shows the change in the amount of egg content added by TLC and confirmation of residual cholesterol and androgen production in fermentation broth.

도 4는 본 발명의 발효생성물을 적용한 눈썹에 대한 영향을 보여준다.Figure 4 shows the effect on the eyebrow to which the fermentation product of the present invention is applied.

Claims (6)

삭제delete 삭제delete 삭제delete 삭제delete 스테롤을 포함하는 계란에 포도당이 배양 배지 중량의 2 ~ 3 중량% 농도로 첨가된 Mycobacterium 속 M3805 균주(KCTC 1829)를 함유하는 종 배양액을 5 ~ 500중량% 양으로 접종하고, 섭씨 20 ~ 40 도에서 5 ~ 100일 배양하는 것을 특징으로 하는 발효생성물의 최종 스테롤 함량이 초기 스테롤 함량의 50 중량% 이하인 저 스테롤 또는 무 스테롤이며 안드로겐을 포함하는 발효생성물을 제조하는 방법.A seed culture solution containing Mycobacterium spp. M3805 strain (KCTC 1829) added to the sterol containing egg at a concentration of 2 to 3% by weight of the culture medium was inoculated in an amount of 5 to 500% by weight, and 20 to 40 degrees Celsius. The final sterol content of the fermentation product, characterized in that incubated for 5 to 100 days at 50 wt% or less of the initial sterol content is a low sterol or sterol-free method for producing a fermentation product containing androgen. 삭제delete
KR1020090027297A 2009-03-31 2009-03-31 The microbial fermented products of androgen from natural products containing sterol and its production method KR101116180B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020090027297A KR101116180B1 (en) 2009-03-31 2009-03-31 The microbial fermented products of androgen from natural products containing sterol and its production method
PCT/KR2010/001858 WO2010114255A2 (en) 2009-03-31 2010-03-26 Androgen-containing product obtained by fermenting sterol-containing natural substance using microorganisms, and method for preparing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090027297A KR101116180B1 (en) 2009-03-31 2009-03-31 The microbial fermented products of androgen from natural products containing sterol and its production method

Publications (2)

Publication Number Publication Date
KR20100108958A KR20100108958A (en) 2010-10-08
KR101116180B1 true KR101116180B1 (en) 2012-03-06

Family

ID=42828816

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090027297A KR101116180B1 (en) 2009-03-31 2009-03-31 The microbial fermented products of androgen from natural products containing sterol and its production method

Country Status (2)

Country Link
KR (1) KR101116180B1 (en)
WO (1) WO2010114255A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397946A (en) * 1980-06-17 1983-08-09 Mitsubishi Chemical Industries Limited Process for preparing androstane steroids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100432054B1 (en) * 2001-05-11 2004-05-17 (주)유진사이언스 Microorganism having ability to convert sterol into Androst-4-ene-3,17-dione/Androsta-1,4-diene-3,17-dione and preparation method thereof
KR100422161B1 (en) * 2001-05-11 2004-03-10 (주)유진사이언스 A method for preparation of Androst-4-ene-3,17-dione and Androsta-1,4-diene-3,17-dione
KR100418657B1 (en) * 2001-10-16 2004-02-11 주식회사 엘지생명과학 9-alpha-hydroxy-androst-4-en-3,17-dion manufacturing method using Mycobacterium sp.
KR100592465B1 (en) * 2003-06-30 2006-06-22 (주)유진사이언스 Method for preparing 4-androsten-3,17-dione and androstar-1,4-diene-3,17-dione using two-step fermentation process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397946A (en) * 1980-06-17 1983-08-09 Mitsubishi Chemical Industries Limited Process for preparing androstane steroids

Also Published As

Publication number Publication date
WO2010114255A9 (en) 2012-05-18
KR20100108958A (en) 2010-10-08
WO2010114255A3 (en) 2011-03-10
WO2010114255A2 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
US20130011384A1 (en) Use of a Material, Produced from Fungal Fermentation, as a Food Supplement
Li et al. In vitro fecal fermentation characteristics of bamboo shoot (Phyllostachys edulis) polysaccharide
KR20160065245A (en) Composition of culture medium for cultivation of Lactobacillus, ginseng berry-fermented extracts comprising thereof and cosmetic composition for improving skin conditions
KR20150083290A (en) Method for preparing ginsenoside derivative and composition comprising ginsenoside derivative prepared by the same for whitening and improving wrinkle
Sun et al. Enhancement of ganoderic acid production by promoting sporulation in a liquid static culture of Ganoderma species
David et al. Fermented rice bran extract improves blood pressure and glucose in stroke-prone spontaneously hypertensive rats
KR101628756B1 (en) Novel Lactobacillus pentosus NEO 1 and extracts from ginseng-fermented products using Lactobacillus pentosus NEO 1 and manufacturing method thereof
CN108925982A (en) A kind of preparation method of high anti-oxidation activity pomegranate ferment
Liu et al. Characteristic analysis of peptide fraction extracted from Dendrobium aphyllum after in vitro gastrointestinal digestion and fermentation by human fecal microbiota
KR101980450B1 (en) Composition of active wild-cultivated ginseng having increased ginsenoside Rd and compound K, chlorgenic acid and quercetin, and preparation method thereof
KR101806992B1 (en) Cosmetic compositions for preventing skin cell death comprising extracts of fermented red ginseng
KR101116180B1 (en) The microbial fermented products of androgen from natural products containing sterol and its production method
KR20190071017A (en) Manufacturing method of Health Food using honeybee pollen
WO2020091192A9 (en) Matured mixed fermentation product of wild-cultivated ginseng in which ginsenoside absorbable in human body and omega-6 fatty acid are increased, and preparation method therefor
JP4387760B2 (en) Antioxidant composition
Wang et al. Effects of Eucommia ulmoides Oliver leaves on gut microbiota and intestinal function during in vitro simulated digestion and fermentation
CN114081862B (en) Preparation and application of Saccharomyces cerevisiae fermentation product from highland barley wine distiller's yeast in Pan-Himalaya region
KR20090043758A (en) Composition for improvement of fatty liver
KR20160013389A (en) Method for Manufacturing Fermented Allium hookeri, and Fermented Allium hookeri Produced Thereby
KR20080081393A (en) Hair growth promoting composition having extract of pogostemon cablin, sunflower, cinnamomum cassia blume
KR102545365B1 (en) Fermentation composition of mountain-cultivated ginseng having increased ginsenoside Rd, Rc and Protopanaxadiol by using Tricholoma matsutake mycelium and preparation method thereof
KR102482910B1 (en) Composition of complex-fermented Fabaton soybean leaves having increased aglycon isoflavones, oleic acid and niacin, and preparation method thereof
KR102383063B1 (en) Natural fermentation vinegar using dendropanax morbiferus and dropwort, Manufacturing method thereof, and functional health food for protecting and improving a liver and kidney
CN114949039B (en) Plant ferment and use thereof for producing lipid-reducing compositions
KR20090081707A (en) Inihition composite symptoms irritable colon syndrome

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20150130

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160121

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170725

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180206

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20190219

Year of fee payment: 8